OneSource Specialty Pharma

Stelis Biopharma (formerly Agila Specialties), a subsidiary of Strides Arcolab Ltd, is a full services player with a well diversified portfolio of products across categories that include high potency drugs like oncology, Penems, Penicillins, Cephalosporins, Ophthalmics, Peptides, Controlled Substances. In December 2013, Mylan acquired the injectable business of the company from Strides Arcolab.In September 2012, the company received approval for its 'Polish Sterile facility' in the injectables unit of Strides Acrolab Limited from the US FDA. By that time, totally eight injectable had been approved by the US FDA and European authorities cGMP manufacturing facility.In June 2011, Agila Specialties signed an agreement to establish a manufacturing plant with Bio-XCell, Malaysia. In July 2014, parent company Strides Acrolab disclosed that further delays were expected in the manufacturing facility setup in Malaysia. In December 2014, the company began construction of multi